Terray Therapeutics, a pioneer in drug discovery, has secured an infusion of capital from NVentures, the venture arm of tech giant NVIDIA. Based in Los Angeles, the company is also backed by influential players like John Maraganore and Bassil Dahiyat, marking a significant bet on its innovative approach to small molecule therapeutics.

With this strategic investment, Terray aims to accelerate its groundbreaking work, blending cutting-edge biotech with NVIDIA's computational expertise to revolutionize medicine.